Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| mast cell | 6 studies | 23% ± 9% | |
| endothelial cell | 6 studies | 26% ± 8% | |
| natural killer cell | 5 studies | 19% ± 2% | |
| epithelial cell | 5 studies | 30% ± 12% | |
| microglial cell | 5 studies | 23% ± 7% | |
| B cell | 4 studies | 20% ± 5% | |
| retina horizontal cell | 4 studies | 23% ± 8% | |
| type B pancreatic cell | 3 studies | 35% ± 13% | |
| classical monocyte | 3 studies | 28% ± 8% | |
| hematopoietic precursor cell | 3 studies | 23% ± 3% | |
| non-classical monocyte | 3 studies | 26% ± 9% | |
| fibroblast | 3 studies | 22% ± 4% | |
| pancreatic A cell | 3 studies | 31% ± 11% | |
| plasmacytoid dendritic cell | 3 studies | 17% ± 2% | |
| oligodendrocyte | 3 studies | 22% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 2529.78 | 459 / 459 | 100% | 29.17 | 1118 / 1118 |
| esophagus | 100% | 1676.16 | 1445 / 1445 | 100% | 18.53 | 183 / 183 |
| liver | 100% | 1034.50 | 226 / 226 | 100% | 15.33 | 406 / 406 |
| ovary | 100% | 1887.78 | 180 / 180 | 100% | 18.01 | 430 / 430 |
| uterus | 100% | 2124.06 | 170 / 170 | 100% | 19.39 | 459 / 459 |
| brain | 100% | 2030.29 | 2639 / 2642 | 100% | 19.20 | 705 / 705 |
| prostate | 100% | 1745.07 | 245 / 245 | 100% | 19.20 | 500 / 502 |
| thymus | 100% | 1856.55 | 652 / 653 | 100% | 20.43 | 603 / 605 |
| lung | 99% | 1623.87 | 575 / 578 | 100% | 22.13 | 1155 / 1155 |
| bladder | 100% | 1825.90 | 21 / 21 | 99% | 15.89 | 501 / 504 |
| adrenal gland | 100% | 2998.02 | 258 / 258 | 98% | 18.59 | 226 / 230 |
| stomach | 100% | 1324.15 | 359 / 359 | 98% | 13.66 | 281 / 286 |
| kidney | 100% | 1620.37 | 89 / 89 | 98% | 14.48 | 883 / 901 |
| intestine | 100% | 1793.40 | 966 / 966 | 98% | 14.38 | 515 / 527 |
| pancreas | 98% | 873.25 | 321 / 328 | 99% | 15.36 | 176 / 178 |
| skin | 100% | 2363.79 | 1808 / 1809 | 95% | 28.87 | 447 / 472 |
| adipose | 100% | 2595.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1916.17 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 16.10 | 29 / 29 |
| muscle | 100% | 3772.69 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2139.39 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 15.53 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 10.15 | 1 / 1 |
| heart | 98% | 1401.09 | 848 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 88% | 1461.62 | 819 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 63% | 7.75 | 50 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007283 | Biological process | spermatogenesis |
| GO_0035194 | Biological process | regulatory ncRNA-mediated post-transcriptional gene silencing |
| GO_0030154 | Biological process | cell differentiation |
| GO_0030422 | Biological process | siRNA processing |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_1902555 | Cellular component | endoribonuclease complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0004521 | Molecular function | RNA endonuclease activity |
| GO_0043565 | Molecular function | sequence-specific DNA binding |
| GO_0003697 | Molecular function | single-stranded DNA binding |
| GO_0044877 | Molecular function | protein-containing complex binding |
| GO_0031687 | Molecular function | A2A adenosine receptor binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | TSNAX |
| Protein name | Translin-associated protein X (Translin-associated factor X) |
| Synonyms | hCG_14691 DKFZp686G1650 TRAX |
| Description | FUNCTION: Acts in combination with TSN as an endonuclease involved in the activation of the RNA-induced silencing complex (RISC). Possible role in spermatogenesis. . FUNCTION: Acts in combination with TSN as an endonuclease involved in the activation of the RNA-induced silencing complex (RISC). Possible role in spermatogenesis. . FUNCTION: Acts in combination with TSN as an endonuclease involved in the activation of the RNA-induced silencing complex (RISC). Possible role in spermatogenesis. . |
| Accessions | ENST00000413309.3 ENST00000366639.9 Q99598 Q5VVQ1 Q7Z3N9 |